Long-Term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Long-Term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

This study is ongoing, but not recruiting participants.
Information provided by Zymenex A/S

Please refer to this study by its ClinicalTrials.gov identifier: NCT00633139

Locations


Denmark, Hvidovre
	PhaseOneTrials A/S
	Copenhagen, Hvidovre, Denmark, 2650

Sponsors and Collaborators

Zymenex A/S

Investigators


Principal Investigator:	Allan M Lund, MD	Rigshospitalet, Denmark